5-MeO-EPT

Category:Articles with short descriptionCategory:Short description is different from Wikidata
5-MeO-EPT
Clinical data
Other names5-Methoxy-N-ethyl-N-propyltryptamine
Drug classSerotonergic psychedelic; Hallucinogen
Legal status
Legal status
Identifiers
  • N-ethyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H24N2O
Molar mass260.381 g·mol−1
3D model (JSmol)
  • CCCN(CC)CCC1=CNC2=C1C=C(C=C2)OC
  • InChI=1S/C16H24N2O/c1-4-9-18(5-2)10-8-13-12-17-16-7-6-14(19-3)11-15(13)16/h6-7,11-12,17H,4-5,8-10H2,1-3H3
  • Key:OQHFIOKNGNJPPF-UHFFFAOYSA-N
Category:Articles without EBI source#*Category:Chemical pages without DrugBank identifier#*Category:Articles without KEGG source#*Category:Drugs missing an ATC codeCategory:Articles containing unverified chemical infoboxes#*

5-MeO-EPT, also known as 5-methoxy-N-ethyl-N-propyltryptamine, is a psychedelic tryptamine derivative which has been sold as a designer drug.[1][2]

Use and effects

5-MeO-EPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).[3]

Interactions

Chemistry

Analogues

Analogues of 5-MeO-EPT include ethylpropyltryptamine (EPT), 4-HO-EPT (eprocin), 5-fluoro-EPT, 5-MeO-MET, 5-MeO-MPT, 5-MeO-MiPT, and 5-MeO-EiPT, among others.

Society and culture

5-MeO-EPT is illegal in Singapore[4] and Japan,[5] as well as falling within the scope of drug analogue laws in a number of other jurisdictions.

See also

References

  1. ↑ Uchiyama N, Miyazawa N, Kawamura M, Kikura-Hanajiri R, Goda Y (February 2010). "[Analysis of newly distributed designer drugs detected in the products purchased in fiscal year 2008]". Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan (in Japanese). 130 (2): 263–70. doi:10.1248/yakushi.130.263. PMID 20118651.Category:CS1 Japanese-language sources (ja)
  2. ↑ Namera A, Nakamoto A, Saito T, Nagao M (January 2011). "Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review". Forensic Toxicology. 29 (1): 1–24. doi:10.1007/s11419-010-0107-9. S2CID 27985415.
  3. ↑ Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.
  4. ↑ "Misuse of Drugs Act - Singapore Statutes Online". sso.agc.gov.sg.
  5. ↑ "指定薬物名称・構造式一覧（平成27年9月16日現在）" (PDF) (in Japanese). 厚生労働省. 16 September 2015.Category:CS1 Japanese-language sources (ja)
Category:Designer drugs Category:N,N-Dialkyltryptamines Category:5-Methoxytryptamines Category:Psychedelic tryptamines Category:Serotonin receptor agonists Category:Tertiary amines
Category:5-Methoxytryptamines Category:Articles containing unverified chemical infoboxes Category:Articles with short description Category:Articles without EBI source Category:Articles without KEGG source Category:CS1 Japanese-language sources (ja) Category:Chemical pages without DrugBank identifier Category:Designer drugs Category:Drugs missing an ATC code Category:Drugs with non-standard legal status Category:N,N-Dialkyltryptamines Category:Psychedelic tryptamines Category:Serotonin receptor agonists Category:Short description is different from Wikidata Category:Short description matches Wikidata Category:Tertiary amines